Development asset linked to Abott Laboratories in public FDA and regional records.
pharma · Influenza immunisation
Abott Laboratories
Abbott Laboratories
Abott Laboratories drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Moscow, RU HQ
576 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Moscow, RU
- Employees
- 576
- Programs
- 1
- Drugs
- 4
- Patents
- 25
Abott Laboratories pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Abott Laboratories drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
influenza vaccine (live attenuated, nasal)
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in Abott Laboratories's portfolio.
-
Development asset linked to Abott Laboratories in public FDA and regional records.
-
Development asset linked to Abott Laboratories in public FDA and regional records.